Silva Pharmaceuticals Limited announcements
119 Dhaka Stock Exchange announcements for Silva Pharmaceuticals Limited (SILVAPHL) since 2018: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (18).
- Credit Rating Result
Credit Rating Agency of Bangladesh Limited (CRAB) has assigned Surveillance entity rating of the Company as "A3" in the long term and "ST-1" in the short term along with Stable outlook based on audited financial statements (FYE June 30, 2022-2024), bank liability as on October 30, 2024 and other information up to the date of rating declaration.
- Resumption after Record date
Trading of the shares of the company will resume on 02.12.2024.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 01.12.2024.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 27.11.2024 to 28.11.2024 and trading of the shares will remain suspended on record date i.e., 01.12.2024.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. (0.24) for July-September 2024 as against Tk. (0.06) for July-September 2023; NOCFPS was Tk. 0.07 July-September 2024 as against Tk. 0.08 for July-September 2023. NAV per share was Tk. 16.29 as on September 30, 2024 and Tk. 16.53 as on June 30, 2024. (cont.) (Cont. news of SILVAPHL): Reasons for deviation: EPS has decreased due to decrease in sales volume and increase in cost of goods sold. NAVPS has decreased due to net loss incurred in this period. NOCFPS has decreased compared to the same period of precious year due to decrease in collection from receivables as well as sales. (end)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2024 at 4:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
- The Board of Directors has recommended 1\% cash dividend for shareholders excluding the Sponsors and Directors for the y
The Board of Directors has recommended 1\% cash dividend for shareholders excluding the Sponsors and Directors for the year ended June 30, 2024. The Sponsors/Directors, who shall not be entitled to the recommended cash dividend, hold 69,034,952 shares out of total 136,500,000 shares. The total amount of cash dividend payable to the general shareholders is Tk. 6,746,505.00 only for 67,465,048 shares. Date of AGM: 30.12.2024, Time: 10:30 AM, (cont.)
- Dividend Declaration
(Continuation news of SILVAPHL): Venue: Hybrid System, Record Date: 01.12.2024. The Company has reported EPS of Tk. (0.47), NAV per share of Tk. 16.53 and NOCFPS of Tk. 0.003 for the year ended June 30, 2024 as against Tk. 0.24, Tk. 17.10 and Tk. 0.51 respectively for the year ended June 30, 2023. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (29.10.2024) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2024 at 4:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
- (Q3 Un-audited): EPS was Tk. 0.04 for January-March 2024 as against Tk. 0.06 for January-March 2023; EPS was Tk. (0.08)
(Q3 Un-audited): EPS was Tk. 0.04 for January-March 2024 as against Tk. 0.06 for January-March 2023; EPS was Tk. (0.08) for July 2023-March 2024 as against Tk. 0.39 for July 2022-March 2023. NOCFPS was Tk. 0.24 for July 2023-March 2024 as against Tk. 0.88 for July 2022-March 2023. NAV per share was Tk. 16.92 as on March 31, 2024 and Tk. 17.10 as on June 30, 2023. Reasons for deviation in EPS and NOCFPS: (cont.1)
- (Continuation news of SILVAPHL): During the reported period from July 1, 2023 to March 31, 2024 the Net profit after tax
(Continuation news of SILVAPHL): During the reported period from July 1, 2023 to March 31, 2024 the Net profit after tax and EPS were decreased comparison to the same period of the previous year due to increase in cost of goods sold for disruption of global supply chain caused increase of all input raw material (Local and imported) price caused by appreciation of US Dollar against BDT, (cont.2)
The first part of this announcement is missing from the archive. - Q3 Financials
(Continuation news of SILVAPHL): increase of utility cost and other relevant overhead and also decrease in the sales volume as compared to the previous year same period. NOCFPS decreased due to sales revenue decreased and collections also decreased during July 2023 to March 2024 period. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2024 at 03:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2024.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2023 to the respective shareholders.
- (Q2 Un-audited): EPS was Tk. (0.06) for October-December 2023 as against Tk. 0.14 for October-December 2022; EPS was Tk.
(Q2 Un-audited): EPS was Tk. (0.06) for October-December 2023 as against Tk. 0.14 for October-December 2022; EPS was Tk. (0.12) for July-December 2023 as against Tk. 0.33 for July-December 2022. NOCFPS was Tk. 0.17 for July-December 2023 as against Tk. 0.54 for July-December 2022. NAV per share was Tk. 16.88 as on December 31, 2023 and Tk. 17.10 as on June 30, 2023. Reasons for Deviation in EPS, NOCFPS and NAVPS: EPS has been decreased compared to the same period (cont.)
- Q2 Financials
(Continuation news of SILVAPHL): of the previous year due to decrease in sales revenue and also increase in production cost for increase in all input raw material prices, significant volatile of the foreign currency market and limitation for opening LC to import raw materials. NAVPS has been decreased due to net loss incurred in this period and NOCFPS has decreased compare to previous year's same period due to decrease in collection from receivables as well as sales. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2024 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.